Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,625,390 cases with around 603,960 deaths. India confirmed a total of at least 30,279,330 cases and 396,730 deaths, while Brazil reported over 18,420,590 COVID-19 cases with 513,470 deaths. In total, there were at least 181,167,050 cases of COVID-19 worldwide with more than 3,924,860 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Information technology shares jumped by 1.1% on Monday. Meanwhile, top gainers in the sector included QAD Inc. QADB, up 79%, and JinkoSolar Holding Co., Ltd. JKS, up 21%.
In trading on Monday, energy shares fell 3.3%.
Top Headline
Perion Network Ltd PERI reported preliminary second-quarter FY21 revenue growth of 74% year-on-year to $105 million, exceeding the consensus of $95.86 million.
Perion Network raised the FY21 revenue guidance from the previous $390 million - $410 million to $410 million- $430 million. The Adjusted EBITDA outlook increased from $39 million - $41 million to $49 million $51 million.
Equities Trading UP
Intellia Therapeutics, Inc. NTLA shares shot up 47% to $130.89 after the company announced positive clinical data for its CRISPR therapy.
Shares of QAD Inc. QADB got a boost, shooting 80% to $86.32 after the company announced it will be acquired by Thoma Bravo for $2 billion, or $87.50 per share in cash.
New Senior Investment Group Inc. SNR shares were also up, gaining 29% to $8.94. Ventas announced plans to acquire New Senior Investment Group in a transaction valued at $2.3 billion.
Check out these big movers of the day
Equities Trading DOWN
CEL-SCI Corporation CVM shares tumbled 44% to $14.14. CEL-SCI announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell carcinoma of the head and neck (SCCHN).
Shares of Kiromic BioPharma, Inc. KRBP were down 25% to $7.52. Kiromic Biopharma announced the company will be presenting at 2021 Next-Gen Immuno Oncology Congress showcasing its proprietary AI targets for off-the-shelf allogenic CAR-T for solid tumors.
Exelixis, Inc. EXEL was down, falling 20% to $18.82 after the company provided a data update on its Phase 3 trial in patients with previously untreated advanced liver cancer.
Commodities
In commodity news, oil traded down 1.4% to $73.05, while gold traded up 0.1% to $1,779.60.
Silver traded up 0.3% Monday to $26.17 while copper fell 0.4% to $4.2745.
Euro zone
European shares were lower today. The eurozone’s STOXX 600 slipped 0.59%, the Spanish Ibex Index fell 1.93% and the German DAX 30 fell 0.36%. Meanwhile, the London’s FTSE 100 fell 0.89%, French CAC 40 dropped 0.99% and Italy’s FTSE MIB declined 1.02%.
Import prices in Germany increased 11.8% year-over-year in May versus a 10.3% surge in the earlier month .
Economics
The Dallas Fed manufacturing index for June is scheduled for release at 10:30 a.m. ET. After a strong 34.9 reading in May, analysts expect the index retreating to 32.5 in June.
Fed Vice Chairman for Supervision Randal Quarles is set to speak at 1:10 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
